{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T20:43:09Z","timestamp":1774212189370,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.neurobiolaging.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:46:34Z","timestamp":1612489594000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age"],"prefix":"10.1016","volume":"102","author":[{"given":"Samantha L.","family":"Allison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Jonaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Koscik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce P.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly D.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Cary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard A.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara B.","family":"Bendlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0001","series-title":"Selected Papers of Hirotugu Akaike","first-page":"371","article-title":"Factor analysis and AIC","author":"Akaike","year":"1987"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101895","article-title":"Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease spectrum","volume":"23","author":"Allison","year":"2019","journal-title":"NeuroImage Clin."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0004","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","article-title":"Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis","volume":"19","author":"B\u00e4ckman","year":"2005","journal-title":"Neuropsychology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.02.012","article-title":"Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies","volume":"93","author":"Baiano","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0007","first-page":"108","article-title":"Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: a meta-analysis","volume":"6","author":"Baker","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0008","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.52.6.1153","article-title":"Medial temporal lobe atrophy on MRI in dementia with Lewy bodies","volume":"52","author":"Barber","year":"1999","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0009","first-page":"82","article-title":"[18F] MK-6240 PET quantification and image feature characterization from controls to Alzheimer's disease","volume":"59","author":"Betthauser","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2967\/jnumed.118.209650","article-title":"In vivo characterization and quantification of neurofibrillary Tau PET radioligand 18F-MK-6240 in humans from alzheimer disease dementia to young controls","volume":"60","author":"Betthauser","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0011","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awy150","article-title":"Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults","volume":"141","author":"Bilgel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0013","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neurobiolaging.2006.05.006","article-title":"CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment","volume":"28","author":"Bouwman","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"338","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer's disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1006\/nimg.2002.1197","article-title":"Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry","volume":"17","author":"Burton","year":"2002","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0016","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson's disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease","volume":"67","author":"Ch\u00e9telat","year":"2010","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0018","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","article-title":"Accelerated cortical atrophy in cognitively normal elderly with high \u03b2-amyloid deposition","volume":"78","author":"Ch\u00e9telat","year":"2012","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0019","doi-asserted-by":"crossref","first-page":"e1306","DOI":"10.1212\/WNL.0000000000005291","article-title":"Age-accelerated cognitive decline in asymptomatic adults with CSF \u03b2-amyloid","volume":"90","author":"Clark","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0020","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.neurobiolaging.2010.05.023","article-title":"Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification","volume":"32","author":"Davatzikos","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0021","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hipo.20432","article-title":"Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia","volume":"18","author":"Di Paola","year":"2008","journal-title":"Hippocampus"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid A\u03b242 correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0023","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0024","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneurol.2007.27","article-title":"Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve","volume":"65","author":"Fotenos","year":"2008","journal-title":"Arch. Neurol."},{"issue":"9170","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0025","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(99)00496-1","article-title":"Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease","volume":"353","author":"Fox","year":"1999","journal-title":"Lancet North Am. Ed."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JAD-2007-12103","article-title":"Brain reserve hypothesis in dementia","volume":"12","author":"Fratiglioni","year":"2007","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"6-7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0028","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/13854046.2016.1277557","article-title":"The statistical crisis in science: how is it relevant to clinical neuropsychology?","volume":"31","author":"Gelman","year":"2017","journal-title":"Clin. Neuropsychol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11065-017-9366-0","article-title":"Detectable neuropsychological differences in early preclinical Alzheimer's disease: a meta-analysis","volume":"27","author":"Han","year":"2017","journal-title":"Neuropsychol. Rev."},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"80","author":"Hedden","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0031","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/01.wnl.0000344568.09360.31","article-title":"Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures","volume":"72","author":"Henneman","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0032","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0033","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0034","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.58.5.750","article-title":"Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia","volume":"58","author":"Jack","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.55.4.484","article-title":"Rates of hippocampal atrophy correlate with change in clinical status in aging and AD","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0036","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/brain\/awv283","article-title":"Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings","volume":"138","author":"Jack","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0037","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0038","first-page":"130","article-title":"The Wisconsin Registry for Alzheimer's prevention: a review of findings and current directions","volume":"10","author":"Johnson","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0039","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.neuroimage.2010.01.064","article-title":"A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T)","volume":"50","author":"Keihaninejad","year":"2010","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0041","doi-asserted-by":"crossref","unstructured":"Kuhlmann, J., Andreasson, U., Pannee, J., Bjerke, M., Portelius, E., Leinenbach, A., & Blennow, K.; IFCC Working Group on Standardization of CSF proteins (WG-CSF). (2017). CSF A\u03b21-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation. Clin. Chim. Acta, 467, 27-33.","DOI":"10.1016\/j.cca.2016.05.014"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest Package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Software"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0044","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2009.08.017","article-title":"Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease","volume":"32","author":"Lehmann","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0045","first-page":"P393","article-title":"Transformation of CSF biomarker values between measurement batches","volume":"14","author":"Ma","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0046","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0047","first-page":"129","article-title":"Differential effects of neurodegeneration biomarkers on subclinical cognitive decline","volume":"5","author":"Merluzzi","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0048","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0049","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0051","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nicl.2017.08.022","article-title":"Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease","volume":"16","author":"Pettigrew","year":"2017","journal-title":"NeuroImage Clin."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0052","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0053","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and\" preclinical\" Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0054","series-title":"R: A Language and Environment for Statistical Computing 2017","author":"Core Team","year":"2016"},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0055","article-title":"L'examen psychologique dans les cas d'enc\u00e9phalopathie traumatique.(Les problems.)","author":"Rey","year":"1941","journal-title":"Arch. de Psychol"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0056","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0057","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.58.2.198","article-title":"Patterns of brain atrophy in frontotemporal dementia and semantic dementia","volume":"58","author":"Rosen","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0058","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroimage.2009.06.074","article-title":"Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast","volume":"48","author":"Salat","year":"2009","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0059","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A\u03b21-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann. Stat."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0061","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaneurol.2016.0194","article-title":"Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change","volume":"73","author":"Soldan","year":"2016","journal-title":"JAMA Neurol."},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0062","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","article-title":"ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes","volume":"92","author":"Soldan","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0063","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11682-016-9566-x","article-title":"An approach to studying the neural correlates of reserve","volume":"11","author":"Stern","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0064","article-title":"Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance","author":"Stern","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0065","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-\u03b2 peptide deposition identified with Pittsburgh compound B: cognitive decline associated with A\u03b2 deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0066","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF A\u03b2 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0067","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-142451","article-title":"Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e","volume":"45","author":"Susanto","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0068","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid \u03b2-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0069","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neurobiolaging.2011.05.018","article-title":"Structural MRI changes detectable up to ten years before clinical Alzheimer's disease","volume":"33","author":"Tondelli","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jamaneurol.2017.2712","article-title":"Interpreting biomarker results in individual patients with mild cognitive impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) project","volume":"74","author":"van Maurik","year":"2017","journal-title":"JAMA Neurol."},{"issue":"17","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0071","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/WNL.0b013e3182704056","article-title":"Injury markers predict time to dementia in subjects with MCI and amyloid pathology","volume":"79","author":"van Rossum","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0072","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0073","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.030_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","article-title":"NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers","volume":"44","author":"Vos","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.01.030_bib0075","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.0000000000001401","article-title":"Spatially distinct atrophy is linked to \u03b2-amyloid and tau in preclinical Alzheimer disease","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:27Z","timestamp":1759318707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":74,"alternative-id":["S0197458021000373"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.030","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}